Objective To study the relationship between serum cystatin C (Cys C) level and clinical features in patients with neurosyphilis, and evaluate its clinical significance.
Methods We collected 30 patients as neurosyphilis group, 30 patients as syphilis (non-neurosyphilis, N-NS) group and 20 healthy as control group between September 2016 and May 2018. The levels of serum Cys C were tested by using immunology turbidimetric method. The clinical and laboratory characteristics were compared among the three groups.
Results The patients with neurosyphilis had higher serum Cystatin C levels as compared with the patients with syphilis and healthy control (
P<0.05); however, no significant difference between the N-NS and control group (
P>0.05). Serum Cystatin C level was significantly decreased in neurosyphilis group after the antisyphilitic treatment (
P<0.05). The mean ROC-plot AUC for Cys C was 0.71 [
P=0.022, 95%
CI(0.53,0.89)]. The optimal threshold value for Cys C was 1.09 mg/L with the sensitivity of 55% and specificity of 90%. The correlation analysis showed that the serum Cys C levels were positively associated with CSF protein levels and MMSE score (
r=0.232,
P=0.012;
r=0.273,
P=0.003), but not associated significantly with RPR titer, CSF cell count and CSF pressure (
r=0.413,
P=0.154;
r=0.313,
P=0.446;
r=-0.124,
P=0.142) in patients with neurosyphilis.
Conclusion The levels of serum Cys C is significantly associate with neurosyphilis. To test the levels of Cys C can evaluate the severity of the disease and predict the risk of getting neurosyphilis.